Table S1. Baseline characteristics of included patients.
Study author | Age (years) | Male (%) | HTN (%) | DM (%) | CAD (%) | AF (%) | LVEF (%) | NYHA class III–IV (%) | Prior MI (%) | IE (%) | Concomitant surgery (%) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CABG | TVS | AVS | |||||||||||
Ailawadi et al. (11) | 78/79 | 51/38 | 56/45 | 17/19 | 57/34* | 36/51 | NA | 26/27 | NA | 0/2 | 46/32 | 7/15 | 3/11 |
Chikwe et al. (12) | 83/83 | 52/59 | NA | 22/20 | NA | NA | 52/56 | NA | 15/11 | 2/14* | 47/48 | 36/20* | 0/0 |
DiGregorio et al. (13) | 82/82 | 61/46 | NA | 2/8 | NA | 52/46 | 63/63 | 80/77 | NA | 4/8 | 0/0 | 20/31 | 0/0 |
Gaur et al. (14) | 77/78 | 50/54 | 69/76 | 17/19 | NA | NA | 55/60 | NA | NA | 1/9* | 49/50 | 17/27 | 0/0 |
Gogbashian et al. (15) | 75/77 | 51/42 | 39/31 | 5/6 | 13/6 | NA | 57/58 | 62/61 | 8/0 | 0/0 | 33/51 | 8/28* | NA |
Nloga et al. (16) | 82/81 | 59/70 | NA | 1/17* | 7/15 | 12/7 | NA | 47/67 | NA | 0/0 | 12/20 | 9/2 | 8/32* |
Silaschi et al. (17) | 79/78 | 57/48 | 63/53 | 11/12 | 25/29 | NA | NA | 46/65* | 21/8* | 0/0 | 44/32* | 15/14 | 0/0 |
Data were provided as mitral valve repair/replacement groups. *, significant differences between study groups. AF, atrial fibrillation; AVS, aortic valve surgery; CABG, coronary artery bypass grafting; CAD, coronary artery disease; DM, diabetes mellitus; HTN, hypertension; IE, infective endocarditis; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NA, not applicable; NYHA, New York Heart Association; TVS, tricuspid valve surgery.